Partial FMRP expression is sufficient to normalize neuronal hyperactivity in Fragile X neurons

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• Fragile X syndrome (FXS) is a leading genetic cause of intellectual disability.
• It stems from a CGG repeat expansion in the FMR1 gene, leading to absent FMRP protein and neuronal hyperactivity.
• Understanding the FMRP threshold for phenotype rescue is vital for FXS therapeutics.

Purpose of the Study:

• To determine the minimum FMRP levels required to correct FMRP-dependent neuronal hyperactivity in FXS.
• To model FXS in vitro using patient-derived neurons and titrate FMRP expression.

Main Methods:

• Utilized induced pluripotent stem cell (iPSC)-derived excitatory neurons from FXS patients.
• Employed CRISPR, antisense, and expression technologies to precisely control FMRP levels.
• Developed mosaic neuronal culture systems to assess FMRP restoration in mixed FXS and wild-type (WT) populations.

Main Results:

• Confirmed that FMRP absence causes neuronal hyperactivity in FXS models.
• Demonstrated that restoring >5% overall FMRP expression normalizes neuronal activity.
• Showed that >20% of neurons expressing FMRP in a mosaic pattern is sufficient for phenotype correction.

Conclusions:

• FXS neuronal hyperactivity can be rescued by relatively low levels of FMRP restoration.
• These findings provide critical quantitative targets for FXS gene therapy development.
• Suggests that mosaic FMRP expression may be a viable therapeutic strategy for FXS.